UNSPSC 51432401: Captopril

This classification denotes an ace inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9G64RSX1XD. European Medicines Agency schedules Captopril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06081MIG. Captopril generally arises in the molecular formula C9H15NO3S.

The term CAPTOPRIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, no 10 1978, list 18.) CAPTOPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule captopril under HS 29339990 and SITC 51577. As of Q4 2014, CAPTOPRIL remains the US FDA Preferred Term for this commodity. Captopril bears US NLM identifiers UMLS ID C0006938 and NCI Concept Code C340. SMILES: SCC(C(=O)N1C(CCC1)C(=O)O)C.

UNSPSC 51432401 Captopril, a Commodity code, encompasses prescription medications and active pharmaceutical ingredients that state and local governments procure for emergency medical services, healthcare facilities, and public health programs. State and local procurement under this code focuses on branded and generic formulations supplied to fire rescue departments, health and human services agencies, and cooperative purchasing alliances serving multiple jurisdictions. The issuing bodies include city purchasing departments (such as the City of Tampa), state health and human services commissions (such as the Texas Health and Human Services Commission), and multistate cooperative purchasing organizations (such as the Minnesota Multistate Cooperative Purchasing Alliance). Vendors typically supply through authorized drug wholesalers, with contracts requiring compliance with Good Manufacturing Practices, Drug Supply Chain Security Act certification, FDA approval, expiration-date warranties, and OSHA Safety Data Sheet documentation.

Recent activity spans Florida, Texas, and Minnesota. The City of Tampa's Purchasing Department posted an IFB in April 2026 (Due: April 8, 2026) for Advanced Life Support Medications including Labetalol, Epinephrine, Adenosine, and Diltiazem to supply Tampa Fire Rescue, with an estimated contract value of $40,000 and a Small Local Business Enterprise sheltered-market 5 percent bid discount not to exceed $10,000. The Texas Health and Human Services Commission issued an RFI in April 2026 (Due: April 3, 2026) to gather vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Department of Administration, through MMCAP, posted an RFP in January 2026 (Due: March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local facilities including Oregon, with awards effective July 1, 2026, requiring vendors to maintain relationships with AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co. as authorized wholesalers.